OEA and LipiSperse Metabolic Study

Inclusion Criteria:

• Adults aged 30 years and older

• Generally healthy

• BMI 25.0-34.9 kg/m2

• Able to provide informed consent

• Agree to not participate in another clinical trial while enrolled in this trial

• Agree not to change current diet and/or exercise frequency or intensity duringentire study period

• Females using a prescribed form of birth control (e.g. oral contraceptive)

• Participant's ability to participate fully and comply with demands of the studyincluding attendance at all scheduled blood collection time points

Exclusion Criteria:

• Have a serious illness e.g. neurological disorders such as MS, kidney disease, liverdisease or heart conditions

• History of any glucose or insulin regulation problem, including diabetes.

• Have an unstable illness e.g. thyroid gland dysfunction, uncontrolled mood disorders (e.g., depression, anxiety, bipolar).

• Diagnosed with any known metabolic or endocrine dysfunctions e.g., diabetes, NAFLD,hyperinsulinemia, hypoglycaemia.

• Use of any medication or supplements that may affect any metabolic pathwayassociated with satiety (e.g., GLP-1, GIP, glucagon), glucose or insulin.

• Current malignancy (excluding Basal Cell Carcinoma) or chemotherapy or radiotherapytreatment for malignancy within the previous 2 years

• Significant change in diet in the past 1-month (e.g., removal of a food group orcalorie restriction)

• Active smokers, nicotine use or drug (prescription or illegal substances) abuse

• Chronic past and/or current alcohol use (>21 alcoholic drinks week)

• Pregnant or lactating women

• Allergic to any of the ingredients in active or placebo formula

• Participants who are or who have participated in any other clinical trial during thepast 1 month (excludes RDC clinical trials which are to be assessed on acase-by-case basis).

• Any condition which in the opinion of the investigator makes the participantunsuitable for inclusion

• Regular use within the past 4 weeks of supplements containing OEA and/or LipiSperse